Chinese Community Sample of Hierarchical Model of Psychopathology
NCT06105970 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2025-07-10
Summary
By validating Hierarchy Model of psychopathology(HiTOP) in Chinese community samples, this study aims for illumating the problem of diagnostic heterogeneity and high comorbidity within existing psychiatric classification systems in Chinese culture. Concurrently, this study also focuses on exploring trans-diagonostic risk and proctective factors underline HiTOP dimensions.
the main questions it aims to answer are:
1. Explore HiTOP model cultural differences between western culture and eastern culture.
2. Understand the impact of different dimension of adverse childhood experience on HiTOP structure.
3. Investigate the relationship between individual unique psychological variables and psychopathological dimensions.
Participants will receive a detailed survey trying to measure their psychopathology symptoms, adverse childhood experience and psychological variables. This study expects to fallow up participants for 4 years to monitor the symptom changes.
Conditions
- Mental Health Issue
- Adverse Childhood Experience
Interventions
- OTHER
-
No intervention
cross sectional study#no intervention
Sponsors & Collaborators
-
Shanghai Mental Health Center
lead OTHER
Principal Investigators
-
Zhen Wang, PhD, MD · Shanghai Mental Health Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-26
- Primary Completion
- 2024-11-01
- Completion
- 2027-11-01
Countries
- China
Study Locations
More Related Trials
-
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
NCT07162467 ·Status: ENROLLING_BY_INVITATION
-
The Phase I Study of HS-10509 in Chinese Adult Subjects
NCT06301074 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
The Effectiveness of Assertive Community Treatment on Schizophrenic Patients
NCT04511663 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Traditional Chinese Metacognitive Training (MCT) in Patients With Schizophrenia, Depression, or Bipolar Disorder Attending a Psychiatric Day Hospital in Taiwan
NCT07051746 ·Status: COMPLETED ·Phase: NA
-
Establishing a Clinical Database and Biobank for Schizophrenia:A Cohort Study
NCT06123897 ·Status: RECRUITING
-
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
NCT03451734 ·Status: COMPLETED
-
Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia
NCT01324167 ·Status: UNKNOWN
-
SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia
NCT04528095 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
NCT06673966 ·Status: RECRUITING
-
Early Identification of Mental Disorders: Application of a Multi-modal & Domains System
NCT05939154 ·Status: NOT_YET_RECRUITING
-
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
NCT05542212 ·Status: UNKNOWN ·Phase: NA
-
The Optimal Treatment for Treatment-resistant Schizophrenia
NCT02926976 ·Status: UNKNOWN ·Phase: NA
-
Mental Health During the Whole Life Cycle of Community Patients with Schizophrenia
NCT05159349 ·Status: RECRUITING
-
Epidemiology Study of Psychosis
NCT01423669 ·Status: UNKNOWN
-
ToM Psychotherapy and Brain Networks in EOS
NCT05577338 ·Status: COMPLETED ·Phase: NA
-
Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia
NCT05310955 ·Status: UNKNOWN ·Phase: NA
-
Stage-specific Case Management for Early Psychosis
NCT00919620 ·Status: COMPLETED ·Phase: NA
-
Mindfulness-based Illness Management Program for Schizophrenia
NCT01667601 ·Status: COMPLETED ·Phase: NA
-
Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression
NCT03329287 ·Status: UNKNOWN ·Phase: NA
-
Research on Accurate Prediction of Long-term Medication Use for Schizophrenia Based on Cognitive Function
NCT04513275 ·Status: UNKNOWN
-
The Difference of Grey Matter Volume Among the Patients of Schizophrenia
NCT05262790 ·Status: COMPLETED
-
Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia
NCT00797927 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia
NCT04533724 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations
NCT01075373 ·Status: UNKNOWN
-
The Gut Metagenome Research of Schizophrenia
NCT02708316 ·Status: UNKNOWN